By the same authors

From the same journal

Editors introduction: biobanks as sites of bio-objectification

Research output: Contribution to journal › Article

Standard

Editors introduction: biobanks as sites of bio-objectification. / Stephens, Neil; Brown, Nicholas Gerard Francis; Douglas, Conor .

In: Life Sciences, Society and Policy, Vol. 14, No. 6, 6, 21.02.2018.

Research output: Contribution to journal › Article

Harvard

Stephens, N, Brown, NGF & Douglas, C 2018, 'Editors introduction: biobanks as sites of bio-objectification', Life Sciences, Society and Policy, vol. 14, no. 6, 6. https://doi.org/10.1186/s40504-018-0070-5

APA

Stephens, N., Brown, N. G. F., & Douglas, C. (2018). Editors introduction: biobanks as sites of bio-objectification. Life Sciences, Society and Policy, 14(6), [6]. https://doi.org/10.1186/s40504-018-0070-5

Vancouver

Stephens N, Brown NGF, Douglas C. Editors introduction: biobanks as sites of bio-objectification. Life Sciences, Society and Policy. 2018 Feb 21;14(6). 6. https://doi.org/10.1186/s40504-018-0070-5

Author

Stephens, Neil ; Brown, Nicholas Gerard Francis ; Douglas, Conor . / Editors introduction: biobanks as sites of bio-objectification. In: Life Sciences, Society and Policy. 2018 ; Vol. 14, No. 6.

Bibtex - Download

@article{9f1f17efd99b4da49350b70f36ca4b7f,
title = "Editors introduction: biobanks as sites of bio-objectification",
abstract = "Biobanks and biorepositories have become increasingly important and prevalent since the 1990s as holders and distributors of biological material. They exhibit significant diversity in form and function, from the very small to the very large, from the very specialised to the much more generic, holding collections of diseased and healthy resources, from human, animal and plant, and span private, public and third sectors. They also operate as key mediators in relationships between patients, researchers, regulators and companies as they hold and distribute tissue, data and social credibility. Furthermore, they remain active sites in the mediation of controversy, sometimes causing controversy, sometimes closing controversy. In doing, they become important nodal points of regulatory practice (Douglas et al. 2012; Hansen and Metzler 2012). Their proliferation has resulted in new and dynamic ethical and policy issues in need of critical engagement, some of which are addressed in this thematic issue. A growing literature exists addressing these important issues and opening new ones for inspection. Here we present a set of papers that contribute to this work. The distinctiveness of this thematic issue is the application of a unified theoretical approach.",
author = "Neil Stephens and Brown, {Nicholas Gerard Francis} and Conor Douglas",
year = "2018",
month = feb,
day = "21",
doi = "10.1186/s40504-018-0070-5",
language = "English",
volume = "14",
journal = "Life Sciences, Society and Policy",
issn = "2195-7819",
publisher = "Springer International Publishing AG",
number = "6",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Editors introduction: biobanks as sites of bio-objectification

AU - Stephens, Neil

AU - Brown, Nicholas Gerard Francis

AU - Douglas, Conor

PY - 2018/2/21

Y1 - 2018/2/21

N2 - Biobanks and biorepositories have become increasingly important and prevalent since the 1990s as holders and distributors of biological material. They exhibit significant diversity in form and function, from the very small to the very large, from the very specialised to the much more generic, holding collections of diseased and healthy resources, from human, animal and plant, and span private, public and third sectors. They also operate as key mediators in relationships between patients, researchers, regulators and companies as they hold and distribute tissue, data and social credibility. Furthermore, they remain active sites in the mediation of controversy, sometimes causing controversy, sometimes closing controversy. In doing, they become important nodal points of regulatory practice (Douglas et al. 2012; Hansen and Metzler 2012). Their proliferation has resulted in new and dynamic ethical and policy issues in need of critical engagement, some of which are addressed in this thematic issue. A growing literature exists addressing these important issues and opening new ones for inspection. Here we present a set of papers that contribute to this work. The distinctiveness of this thematic issue is the application of a unified theoretical approach.

AB - Biobanks and biorepositories have become increasingly important and prevalent since the 1990s as holders and distributors of biological material. They exhibit significant diversity in form and function, from the very small to the very large, from the very specialised to the much more generic, holding collections of diseased and healthy resources, from human, animal and plant, and span private, public and third sectors. They also operate as key mediators in relationships between patients, researchers, regulators and companies as they hold and distribute tissue, data and social credibility. Furthermore, they remain active sites in the mediation of controversy, sometimes causing controversy, sometimes closing controversy. In doing, they become important nodal points of regulatory practice (Douglas et al. 2012; Hansen and Metzler 2012). Their proliferation has resulted in new and dynamic ethical and policy issues in need of critical engagement, some of which are addressed in this thematic issue. A growing literature exists addressing these important issues and opening new ones for inspection. Here we present a set of papers that contribute to this work. The distinctiveness of this thematic issue is the application of a unified theoretical approach.

UR - https://doi.org/10.1186/s40504-018-0070-5

U2 - 10.1186/s40504-018-0070-5

DO - 10.1186/s40504-018-0070-5

M3 - Article

VL - 14

JO - Life Sciences, Society and Policy

JF - Life Sciences, Society and Policy

SN - 2195-7819

IS - 6

M1 - 6

ER -

York staff: edit these data